Crum Brian T Insider Trades

Insider Trading History

Track insider trading activity for Crum Brian T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $1.17M 533,821 shares
Last Trade
Feb 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$401k 273,006 shares
$1.47
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $943k 428,802 shares
Last Trade
Feb 28, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$154k 105,019 shares
$1.47
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $749k 340,327 shares
Last Trade
Feb 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$401k 273,006 shares
$1.47
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $989k 449,560 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$982k 749,270 shares
$1.31
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $574k 260,815 shares
Last Trade
Feb 28, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$30.6k 45,622 shares
$0.67
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $1.68M 765,730 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$946k 1,276,220 shares
$0.74
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $390k 177,497 shares
Last Trade
Feb 28, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$67.1k 25,604 shares
$2.62
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $458k 208,160 shares
Last Trade
Feb 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$958k 416,320 shares
$2.30
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $297k 134,798 shares
Last Trade
Feb 28, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$44.6k 20,537 shares
$2.17
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $662k 301,100 shares
Last Trade
Feb 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$732k 301,100 shares
$2.43
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $252k 114,517 shares
Last Trade
Feb 28, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$84.6k 40,880 shares
$2.07
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $219k 99,458 shares
Last Trade
Feb 28, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$31.2k 15,059 shares
$2.07
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $46.3k 21,030 shares
Last Trade
Feb 28, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$84.6k 40,880 shares
$2.07
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, General Counsel & Secr.
Holding Value $517k 234,870 shares
Last Trade
Feb 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$968k 313,160 shares
$3.09
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, General Counsel & Secr.
Holding Value $195k 88,497 shares
Last Trade
Feb 28, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$279k 38,765 shares
$7.19
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, General Counsel & Secr.
Holding Value $92.5k 42,060 shares
Last Trade
Feb 28, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$268k 37,248 shares
$7.19
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, General Counsel & Secr.
Holding Value $162k 73,637 shares
Last Trade
Feb 28, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$107k 14,860 shares
$7.19
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, General Counsel & Secr.
Holding Value $173k 78,760 shares
Last Trade
Feb 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$841k 105,010 shares
$8.01
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, General Counsel & Secr.
Holding Value $123k 56,130 shares
Last Trade
Apr 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37k 19,893 shares
$1.86
$2.20
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, General Counsel & Secr.
Holding Value $109k 49,732 shares
Last Trade
Apr 22, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$12.5k 6,398 shares
$1.96
$2.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up